ArticleERJ open research2024

Untargeted metabolomic analysis reveals different metabolites associated with response to mepolizumab and omalizumab in asthma.

Tanawin Nopsopon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.